论著
ENGLISH ABSTRACT
风湿性二尖瓣成形手术疗效的影响因素分析
贾崧淏
王茂舟
韩杰
姜文剑
张宏家
作者及单位信息
·
DOI: 10.3760/cma.j.cn112434-20240407-00100
Analysis of influencing factors on the outcome of rheumatic mitral valve repair
Jia Songhao
Wang Maozhou
Han Jie
Jiang Wenjian
Zhang Hongjia
Authors Info & Affiliations
Jia Songhao
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
Wang Maozhou
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
Han Jie
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
Jiang Wenjian
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
Zhang Hongjia
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
·
DOI: 10.3760/cma.j.cn112434-20240407-00100
60
14
0
0
1
0
PDF下载
APP内阅读
摘要

目的探索影响风湿性二尖瓣成形手术疗效的影响因素,从而筛选合适的患者接受风湿性二尖瓣成形手术。

方法纳入从2016年1月到2022年3月间876例拟接受风湿性二尖瓣成形手术的患者,通过术前超声心动图和心脏CT多模态影像方法评估患者二尖瓣病变,将成功完成风湿性二尖瓣成形手术且无超过轻度的狭窄或反流定义为良好修复,通过单因素和多因素 logistics回归分析影响风湿性二尖瓣成形手术疗效的影响因素。

结果493例(56.2%)患者完成了效果良好的风湿性二尖瓣成形手术,体质量指数、纽约心功能分级、左心房直径、二尖瓣狭窄程度、二尖瓣反流程度、二尖瓣Agatston评分、乳头肌腱索融合是影响风湿性二尖瓣成形手术疗效的独立影响因素。

结论在风湿性二尖瓣病变中约60%的患者可完成效果良好的二尖瓣成形手术,二尖瓣钙化程度是影响风湿性二尖瓣成形手术疗效的独立危险因素。

风湿性二尖瓣病变;二尖瓣成形术;二尖瓣置换术;超声心动图
ABSTRACT

ObjectiveTo explore the influencing factors on the outcome of rheumatic mitral valve repair, to screen suitable patients for rheumatic mitral valve repair.

MethodsA total of 876 patients who planned to undergo rheumatic mitral valve repair between January 2016 and March 2022 were included in the study. Preoperative echocardiography and cardiac CT imaging were used to evaluate mitral valve disease in patients. Successful completion of rheumatic mitral valve repair without over mild stenosis or regurgitation was defined as satisfactory repair. Univariate and multivariate logistic regression analyses were conducted to identify the influencing factors on the outcome of rheumatic mitral valve repair.

Results493 patients (56.2%) completed satisfactory rheumatic mitral valve repair. BMI, NYHA classification, left atrial diameter, degree of mitral stenosis, degree of mitral regurgitation, Agatston score, and papillary tendon fusion were independent influencing factors on the outcome of rheumatic mitral valve repair.

ConclusionNearly 60% of patients with rheumatic mitral valve disease could complete satisfactory rheumatic mitral valve repair, and the degree of mitral valve calcification was an independent risk factor affecting the outcome of rheumatic mitral valve repair.

Rheumatic mitral valve disease;Mitral valve repair;Mitral valve replacement;Echocardiogram
Zhang Hongjia Email: nc.defudabe.umcc227aijgnohgnahz
引用本文

贾崧淏,王茂舟,韩杰,等. 风湿性二尖瓣成形手术疗效的影响因素分析[J]. 中华胸心血管外科杂志,2025,41(03):163-167.

DOI:10.3760/cma.j.cn112434-20240407-00100

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
风湿性心脏病是最常见的心血管疾病之一,据估算全球范围内现有风湿性心脏病患者约4 050万例,每年造成超过30万人死亡 [ 1 , 2 , 3 ]。风湿性心脏瓣膜病仍是我国瓣膜病的首要病因 [ 4 ],其中超过九成的患者最先累及二尖瓣 [ 5 , 6 ],给社会和患者家庭带来沉重的疾病负担 [ 7 ],因此探索风湿二尖瓣病变的最佳治疗策略是当前重要的临床问题。
我国专家共识推荐对于符合条件的患者优先选择风湿性二尖瓣修复的治疗方案 [ 8 ]。2020年美国心脏协会瓣膜指南也指出,当解剖结构有利时,可以首选交界切开术进行二尖瓣成形手术 [ 9 ]。北京安贞医院瓣膜外科中心通过多年临床实践探索出了针对风湿性二尖瓣病变SCORE四步法成形技术 [ 10 , 11 ],前期研究证实应用该技术进行风湿性二尖瓣成形手术,在中长期随访期间的死亡、瓣膜相关并发症和再次手术方面均显著优于行二尖瓣置换手术 [ 10 ]
在退行性病变中,很多学者主张"全部修复"的观念,即对所有患者均尝试修复 [ 12 ]。但在风湿性病变中成形手术可能并不适用于所有患者,因此需要分析风湿性二尖瓣成形手术疗效的影响因素,从而在临床实践中筛选合适的患者进行风湿性二尖瓣成形手术。本研究纳入了拟进行成形手术的876例风湿性二尖瓣患者,通过多模态影像方法分析患者病变特点,旨在发现影响风湿性二尖瓣成形手术疗效的影响因素,从而筛选合适的患者接受风湿性二尖瓣成形手术,改善患者预后。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Watkins DA , Johnson CO , Colquhoun SM ,et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015[J]. N Engl J Med, 2017,377(8):713-722. doi: 10.1056/NEJMoa1603693 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Marijon E , Mirabel M , Celermajer DS ,et al. Rheumatic heart disease[J]. Lancet, 2012,379(9819):953-964. doi: 10.1016/s0140-6736(11)61171-9 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Roth GA , Mensah GA , Johnson CO ,et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020,76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Wang Z , Ma L , Liu M ,et al. Summary of the 2022 report on cardiovascular health and diseases in China[J]. Chin Med J (Engl), 2023,136(24):2899-2908. doi: 10.1097/cm9.0000000000002927 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Passos LSA , Jha PK , Becker-Greene D ,et al. Prothymosin qlpha: q novel contributor to estradiol receptor alpha-mediated CD8(+) T-Cell pathogenic responses and recognition of type 1 collagen in rheumatic heart valve disease[J]. Circulation, 2022,145(7):531-548. doi: 10.1161/circulationaha.121.057301 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Beaton A , Okello E , Lwabi P ,et al. Echocardiography screening for rheumatic heart disease in ugandan schoolchildren[J]. Circulation, 2012,125(25):3127-3132. doi: 10.1161/circulationaha.112.092312 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Hawkins RB , Strobel RJ , Mehaffey JH ,et al. Contemporary prevalence and outcomes of rheumatic mitral valve surgery[J]. J Card Surg, 2022,37(7):1868-1874. doi: 10.1111/jocs.16369 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
中华医学会胸心血管外科分会瓣膜病外科学组. 风湿性二尖瓣病变外科治疗指征中国专家共识[J]. 中华胸心血管外科杂志 2022,38(3):132-137. doi: 10.3760/cma.j.cn112434-20220126-00026 .
返回引文位置Google Scholar
百度学术
万方数据
The group of valve surgery, Chinese society for thoracic and cardiovascular surgery. Chinese expert consensus on surgical indications of rheumatic mitral valve diseases[J]. Chin J Thorac Cardiovasc Surg, 2022,38(3):132-137. doi: 10.3760/cma.j.cn112434-20220126-00026 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[9]
Otto CM , Nishimura RA , Bonow RO ,et al. 2020 ACC/AHA guideline for the management of opatients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. Circulation, 2021,143(5):e35-e71. doi: 10.1161/cir.0000000000000932 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Fu J , Li Y , Zhang H ,et al. Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease[J]. J Thorac Cardiovasc Surg, 2021,162(1):72-82.e7. doi: 10.1016/j.jtcvs.2020.01.053 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Luo T , Meng X . Rheumatic mitral valve repair: the score procedure[J]. Asian Cardiovasc Thorac Ann, 2020,28(7):377-380. doi: 10.1177/0218492320935251 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Goldstone AB , Cohen JE , Howard JL ,et al. A " Repair-All " strategy for degenerative mitral valve disease safely minimizes unnecessary replacement [J]. Ann Thorac Surg, 2015,99(6):1983-1990;.
返回引文位置Google Scholar
百度学术
万方数据
[13]
Pandian NG , Kim JK , Arias-Godinez JA ,et al. Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease: a report from the American society of echocardiography[J]. J Am Soc Echocardiogr, 2023,36(1):3-28. doi: 10.1016/j.echo.2022.10.009 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Rwebembera J , Marangou J , Mwita J C ,et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease[J]. Nat Rev Cardiol, 2024. 21(4):250-263. doi: 10.1038/s41569-023-00940-9 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Wang M , Zhang H , Liu Z ,et al. Scoring model based on cardiac CT and clinical factors to predict early good mitral valve?repair in rheumatic mitral disease[J]. Eur Radiol, 202434(8):4963-4976. doi: 10.1007/s00330-023-10470-0 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Tian B , Wu F , Han J ,et al. Short-term results on leaflet mobility in patients undergoing rheumatic mitral valve repair with an efficient 4-step commissuroplasty technique[J]. Tex Heart Inst J, 2022,49(6):e217801. doi: 10.14503/thij-21-7801 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Yang Y , Wang Z , Chen Z ,et al. Current status and etiology of valvular heart disease in China: a population-based survey[J]. BMC Cardiovasc Disord, 2021,21(1):339. doi: 10.1186/s12872-021-02154-8 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Dillon J , Yakub MA , Kong PK ,et al. Comparative long-term results of mitral valve repair in adults with chronic rheumatic disease and degenerative disease: is repair for " burnt-out " rheumatic disease still inferior to repair for degenerative disease in the current era? [J]. J Thorac Cardiovasc Surg, 2015,149(3):771-777;.
返回引文位置Google Scholar
百度学术
万方数据
[19]
Yakub MA , Dillon J , Krishna Moorthy PS ,et al. Is rheumatic aetiology a predictor of poor outcome in the current era of mitral valve repair? Contemporary long-term results of mitral valve repair in rheumatic heart disease[J]. Eur J Cardiothorac Surg, 2013,44(4):673-681. doi: 10.1093/ejcts/ezt093 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Vervoort D , Ouzounian M , Yanagawa B . Mitral valve surgery for rheumatic heart disease: replace, repair, retrain?[J]. Curr Opin Cardiol, 2021,36(2):179-185. doi: 10.1097/hco.0000000000000826 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Silverman M , Padala M . Commentary: multifaceted challenges with choosing between mitral va lve repair and replacement for rheumatic heart disease [J]. J Thorac Cardiovasc Surg, 2022,164(1):70-71. doi: 10.1016/j.jtcvs.2020.08.035 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Brescia AA , Watt TMF , Murray SL ,et al. Rheumatic mitral valve repair or replacement in the valve-in-valve era[J]. J Thorac Cardiovasc Surg, 2022,163(2):591-602.e1. doi: 10.1016/j.jtcvs.2020.04.118 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
张宏家 Email: nc.defudabe.umcc227aijgnohgnahz
B

贾崧淏:数据整理、统计学分析、论文撰写;王茂舟、韩杰:数据整理、研究指导;姜文剑、张宏家:研究指导、论文修改、经费支持

C
所有作者均声明不存在利益冲突
D
国家重点研发计划 (2021YFC2501104)
国家自然科学基金 (82170487,82241205)
首都医科大学附属北京安贞医院重大科技创新研发专项 (KCZD202203)
首都医科大学附属北京安贞医院前沿技术预探索项目 (KCQY202201)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号